Advertisement

Topics

Allergan subsidiary gives Syndax rights to acute leukemia treatment

05:57 EDT 18 Oct 2017 | SmartBrief

Allergan subsidiary Vitae Pharmaceuticals granted Syndax Pharmaceuticals exclusive global rights to menin-MLL fusion oncogene -More

Original Article: Allergan subsidiary gives Syndax rights to acute leukemia treatment

NEXT ARTICLE

More From BioPortfolio on "Allergan subsidiary gives Syndax rights to acute leukemia treatment"

Quick Search
Advertisement